Deal Spotlight
Nov 6, 2026November 6, 2026
Yingjiexin Medical raises EUR26M Series B backed by Cornerstone VC and others
EUR26M
round size
series-b
stage
The funding round closed on November 1, 2026, with participation from Cornerstone VC, CICC Capital-affiliated fund, Guanghe Ventures, Houxin Healthcare Investors, Yingyue Fund, Zhuhai Science and Technology Industry Group, and Qiming Venture Capital.
Yingjiexin Medical operates in the Healthcare & Life Sciences sector and is headquartered in China. The company's total raised to date before this round was zero.
Brouky tracks 54 deals in China's Healthcare & Life Sciences sector over the past 12 months, with a median deal size of EUR27.3M.
Related insights
- Deal SpotlightArmatrix raises EUR7.4M in seed round backed by Boundless Venture Co. and Crane
- Deal Spotlight1KOMMA5° raises EUR70M Series C+ backed by B2venture and Marunouchi Innovation Partners
- Cross-Country AnalysisSpain's Seed Startups Show Higher Single-Round Share Than Switzerland
- Cross-Country AnalysisNetherlands and France Show Nearly Identical Single-Round Funding Shares at Early Stages
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.